Loading...
  • protein
  • The vaccine consisted of systemically administered canine oral papillomavirus major coat protein L1 that has been shown to self-assemble into virus-like particles. (vetcontact.com)
  • Because this protein is a good example of a tumor-associated antigen, we have used E7 as a model antigen to test the potential of an experimental vaccine as an immunotherapeutic approach. (aacrjournals.org)
  • Naturally-occurring variants of Human papillomavirus (HPV) 58 have been defined as lineages and sublineages but little is known about the impact of this diversity on protein function. (bioportfolio.com)
  • prevalence
  • As observed in other immunocompromised individuals with selective or combined T cell deficits, the prevalence and morbidity of human papillomavirus (HPV)-related disease is increased in patients with idiopathic CD4 T cell lymphocytopenia (ICL). (clinicaltrials.gov)
  • Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. (springer.com)
  • Dose
  • This vaccine is administered as three separate shots, with the initial dose followed by additional shots given two and six months later. (rxwiki.com)
  • Information has been received from a nurse practitioner concerning an 18 year old female with low level depression and anxiety and penicillin allergy and sulfonamide allergy who on 30-Oct-2006 was vaccinated intramuscularly in the right deltoid with the f"irst dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (lot#653978/0955F). (medalerts.org)
  • The recommended dosing regimen is 3 single injections of 0.5 ml of the vaccine, at day 0, 2 months after the first dose, and 6 months after the first dose. (centerwatch.com)
  • antigen
  • Because most identified tumor-associated antigens are self antigens rather viral antigens, we used E7 transgenic mice to evaluate the E7-based vaccine in conditions where E7 is a self antigen. (aacrjournals.org)
  • strains
  • For all of the indications for use approved by the FDA, the vaccine's full potential for benefit is obtained by those who are vaccinated prior to becoming infected with the HPV strains covered by the vaccine. (rxwiki.com)
  • months
  • Contact your health care provider right away if you get any symptoms that concern you, even several months after getting the vaccine. (rxwiki.com)